Rezolut, CureMetrix launch pilot program in New York

By staff writers

August 6, 2021 -- Rezolut and CureMetrix have launched a pilot program in New York City to improve breast cancer detection in women receiving routine screening mammograms.

Rezolut's diagnostic medical imaging platform will incorporate CureMetrix's artificial intelligence software for screening mammography exams.

The two firms expect results of the pilot program to show that the partnership can result in better mammography workflow and improved performance metrics such as increased cancer detection rates and fewer false positives, they said.

Copyright © 2021

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking